Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
11/2014
11/25/2014US8895286 Attenuated pestiviruses
11/25/2014US8895028 Methods and compositions for dengue virus 3 (DV3) infectious clone
11/25/2014US8895026 Attenuated pestivirus
11/25/2014US8895025 Infectious cDNA of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
11/20/2014US20140342918 Method For Affinity Purification
11/20/2014US20140342434 Removal of contaminating viruses from AAV preparations
11/20/2014US20140342349 Use of at least one biomarker for the in vitro prognosis or diagnosis of lymphoproliferative episodes associated with the epstein-barr virus (ebv)
11/20/2014US20140341982 Vaccination With Immuno-Isolated Cells Producing An Immunomodulator
11/20/2014US20140341949 Vaccine
11/20/2014US20140341948 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
11/20/2014US20140341941 Vaccines and methods for using the same
11/20/2014US20140341923 Human Rhinovirus (HRV) Antibodies
11/20/2014US20140341908 Methods and compositions to modulate antiviral and immune activity responses
11/20/2014US20140341852 Capsid-modified raav vector compositions and methods therefor
11/18/2014US8889398 Composition for inactivating an enveloped virus
11/18/2014US8889397 Nucleotides for prevention and treatment of bacterial and fungal pathologies
11/18/2014US8889181 Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitopes
11/18/2014US8889148 Flavivirus host-range mutations and uses thereof
11/13/2014US20140335607 Methods and compositions relating to restricted expression lentiviral vectors and their applications
11/13/2014US20140335566 Mobile vessel or carrier for the manufacturing production and purification of biologics
11/13/2014US20140335158 Protein and Nucleic Acid Delivery Vehicles, Components and Mechanisms Thereof
11/13/2014US20140335119 POLYPEPTIDE DERIVED FROM gp41, A VACCINE COMPOSITION COMPRISING SAID POLYPEPTIDE, AND USES FOR TREATING AN INFECTION BY AN HIV VIRUS IN AN INDIVIDUAL
11/13/2014US20140335118 Synthetic peptide-based marker vaccine and diagnostic system for effective control of porcine reproductive and respiratory syndrome (prrs)
11/13/2014US20140335117 Identification and Attenuation of the Immunosuppressive Domains in Fusion Proteins of Enveloped RNA Viruses
11/13/2014US20140335116 Avoiding narcolepsy risk in influenza vaccines
11/13/2014US20140335115 Suppressors of mature t cells
11/13/2014US20140335111 Vaccines and immunotherapeutics using il-28 and compositions and methods of using the same
11/13/2014US20140335110 Laser-based vaccine adjuvants
11/13/2014US20140335054 Cns targeting aav vectors and methods of use thereof
11/13/2014US20140335053 Novel mhc class ii restricted t cell epitopes from the cancer antigen, ny eso-1
11/13/2014US20140335047 Drug delivery product and methods
11/11/2014US8883995 Live attenuated influenza virus vaccines comprising microRNA response elements
11/11/2014US8883493 Adenoviral vector comprising herpes simplex virus type 1 thymidine kinase and a transgene for increasing the expression of the transgene
11/11/2014US8883481 Reverse genetics methods for virus rescue
11/11/2014US8883480 Antiviral peptide against avian influenza virus H9N2
11/11/2014US8883479 Method for production of pH stable enveloped viruses
11/11/2014US8883168 Modulation of immune responses by the poxviral K4 protein
11/06/2014US20140329757 Tubulin-interacting protein, caltubin, promotes axonal growth
11/06/2014US20140328877 West nile virus vaccine
11/06/2014US20140328873 Norovirus Immunogens and Related Materials and Methods
11/06/2014US20140328870 Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
11/06/2014US20140328797 Human rhinovirus (hrv) antibodies
11/04/2014US8877492 Compositions and methods for the production of alpha-herpesviruses
11/04/2014US8877448 Method of making recombinant influenza virus
11/04/2014US8877211 Bovine herpes virus vaccine with multiple mutations
11/04/2014US8877210 Influenza hemagglutinin and neuraminidase variants
11/04/2014US8877209 Recombinant influenza vectors with tandem transcription units
11/04/2014US8877175 Long lasting drug formulations
10/2014
10/30/2014US20140323956 Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides
10/30/2014US20140322704 Hepatitis Virus Culture Systems Using Stem Cell-Derived Human Hepatocyte-Like Cells and Their Methods of Use
10/30/2014US20140322700 Method for determining the concentration of virus particles/virus antigens
10/30/2014US20140322174 Novel bacteriophages
10/28/2014US8871734 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury
10/28/2014US8871515 Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof
10/28/2014US8871487 Compositions, methods and uses for inducing viral growth
10/28/2014US8871223 HSV-1 and HSV-2 vaccines and methods of use thereof
10/28/2014US8871222 Recombinant Flavivirus vaccines
10/28/2014US8871193 Viral vectors and their use in therapeutic methods
10/23/2014US20140315294 Scalable lentiviral vector production system compatible with industrial pharmaceutical applications
10/23/2014US20140315277 Novel method
10/23/2014US20140315276 Synthesis of linear and branched polymers of polypeptides through direct conjugation
10/23/2014US20140314858 Ipnv-isav bivalent vaccine using a virus-like particle-based platform and methods of using the same
10/23/2014US20140314811 Herpes simplex virus vaccines
10/23/2014US20140314808 Infectious cdna clone of european prrs virus and uses thereof
10/23/2014US20140314807 Reverse genetics Schmallenberg virus vaccine compositions, and methods of use thereof
10/21/2014US8865461 Rabies virus vector systems and compositions and methods thereof
10/21/2014US8865450 Method for producing continuous cell lines
10/21/2014US8865399 Phage-mediated bioluminescent detection of Yersinia pestis
10/21/2014US8865185 Methods of use for HSV-1 and HSV-2 vaccines
10/21/2014US8865184 Vaccine for chikungunya virus infection
10/21/2014US8865182 Adenoviral-based vectors
10/21/2014US8865158 Bacteriophages for reducing toxicity of bacteria
10/21/2014US8865153 Microorganisms for imaging and/or treatment of tumors
10/16/2014US20140308704 Adenovirus producing novel cell line and the use thereof
10/16/2014US20140308341 Methods and compositions for liposomal formulation of antigens and uses thereof
10/14/2014US8859744 Recombinant hydrogen-producing cyanobacterium and uses thereof
10/14/2014US8859456 Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications
10/14/2014US8859277 Plasmids and phages for homologous recombination and methods of use
10/14/2014US8859276 Recombinant Novirhabdoviruses and uses thereof
10/14/2014US8859257 Vaccinia virus mutants containing the major genomic deletions of MVA
10/14/2014US8859240 Dengue and West Nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
10/14/2014US8859231 Assembly of wild-type and chimeric influenza virus-like particles (VLPs)
10/14/2014US8859208 System producing infectious recombinant influenza virus
10/14/2014US8859198 Detection and use of antiviral resistance mutations
10/09/2014WO2014164697A1 Reverse genetics schmallenberg virus vaccine compositions, and methods of use thereof
10/09/2014WO2014163257A1 Novel infectious bursal disease (ibd) virus k7 strain and vaccine against infectious bursal disease using same
10/09/2014WO2014161974A1 Novel genotypes of chrysodeixis chalcites single nucleopolyhedrovirus (chchsnpv), a procedure for its production and use as a biological control agent
10/09/2014US20140302593 Process for purifying vlps
10/09/2014US20140302091 Methods and compositions for live attenuated viruses
10/09/2014US20140302090 Novel vaccine
10/09/2014US20140302085 Use of gk-1 peptide expressed on m13 filamentous phage as pharmaceutical ingredient to enhance the efficiency of the immune response induced by vaccine or pathogen antigens
10/09/2014US20140302082 Nucleic acid construct comprising nucleic acid derived from genome of hepatitis c virus of genotype 1b, hepatitis c virus genome-replicating cells transfected with the same, and method for producing infectious hepatitis c virus particles
10/09/2014US20140302077 Live attenuated influenza virus
10/07/2014US8852927 Microorganisms for imaging and/or treatment of tumors
10/07/2014US8852915 Method of retrovirus storage
10/07/2014US8852914 Flavivirus vaccines
10/07/2014US8852609 Consensus sequences of chikungunya viral proteins, nucleic acid molecules encoding the same, and compositions and methods for using the same
10/07/2014US8852608 Antibodies against and methods for producing vaccines for respiratory syncytial virus
10/07/2014US8852607 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
10/07/2014US8852602 Immunological herpes simplex virus antigens and methods for use thereof
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... 267